Burkett Financial Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.8K Buy
139
+1
+0.7% +$140 0.01% 246
2026
Q2
$17.5K Buy
138
+1
+0.7% +$132 0.01% 156
2026
Q1
$19.2K Hold
137
– – 0.01% 149
2025
Q4
$16.8K Buy
137
+1
+0.7% +$122 0.01% 144
2025
Q3
$15.1K Buy
136
+1
+0.7% +$114 0.01% 144
2025
Q2
$15K Buy
135
+1
+0.7% +$106 0.01% 136
2025
Q1
$15K Buy
134
+1
+0.8% +$103 0.01% 148
2024
Q4
$12.3K Buy
133
+1
+0.8% +$90 0.01% 137
2024
Q3
$11.1K Buy
132
+1
+0.8% +$76 ﹤0.01% 131
2024
Q2
$8.99K Buy
131
+1
+0.8% +$67 ﹤0.01% 142
2024
Q1
$9.49K Buy
130
+2
+2% +$154 ﹤0.01% 143
2023
Q4
$10.4K Buy
+128
New +$9.96K 0.01% 134

Other funds holding GILD

Burkett Financial Services's GILD Position: Q3 2026 in Review

Burkett Financial Services increased its Gilead Sciences (GILD) stake by 0.72% in Q3 2026, buying an estimated $140 and bringing the position to 139 shares worth $20.8K. The position accounts for 0.01% of the portfolio, ranked #246.

Burkett Financial Services first reported a position in GILD in Q4 2023 and has held it in 12 quarters since. 197 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Burkett Financial Services held 139 shares of Gilead Sciences worth $20.8K as of Q3 2026.
  • Burkett Financial Services bought 1 Gilead Sciences share in Q3 2026, an estimated $140.
  • Gilead Sciences made up 0.01% of Burkett Financial Services's portfolio in Q3 2026, its #246 holding.
  • Burkett Financial Services first reported a position in Gilead Sciences in Q4 2023 and has held it in 12 quarters since.
  • 197 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Burkett Financial Services's 13F filing for Q3 2026, filed 1 Oct 2026.